September is Blood Cancer Awareness month

NeoGenomics stands by the fighters, survivors and caregivers of those with leukemia, lymphoma, and myeloma.

woman drawing chemical chain on glass

Pharma Services

NeoGenomics offers lab services for oncology clinical trials

Learn more

NeoGenomics booth display at trade show event

COVID-19

Precision Medicine during this Crisis

Click here to view

Latest

Presented:
Source: Webinar

Launching a Companion Diagnostic

Research & Development Through Commercialization
Presented:
Source: Webinar

The Role of Liquid Biopsy Testing in Lung Cancer

An overview of testing options for patients with NSCLC
Image
Pharma blog post icon
Published:
Source: Article

Is It Validated?

NeoGenomics has a menu of >600 assays across many different technologies and approaches. Clients…
Published:
Source: Press Release

NeoGenomics Announces Board Appointments

New Tests

Image
Molecular icon
Available: September 23, 2020
Methodology: Molecular

Full Focus Cancer Panel (Germline)

Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on…
Image
IHC icon
Available: September 2, 2020
Methodology: Immunohistochemistry (IHC)

DLL3

Delta-like protein 3 (DLL3) expression is regulated by ASCL1, a transcription factor that is…
Image
FISH icon
Available: August 4, 2020
Methodology: FISH, Molecular

NeoTYPE® Follicular Lymphoma Profile

The NeoTYPE® Follicular Lymphoma Profile analyzes 15 genes through a combination of next-generation…
Image
Molecular icon
Available: August 4, 2020
Methodology: FISH, Molecular

NeoTYPE® Follicular Lymphoma Profile

The NeoTYPE® Follicular Lymphoma Profile analyzes 15 genes through a combination of next-generation…
Image
FISH icon
Available: July 13, 2020
Methodology: FISH

PDGFB Rearrangement (22q13)

Probe(s): PDGFB (22q13.1) Disease(s): Dermatofibrosarcoma protuberans (DFSP)